回复：佩尔-乌诺·马尔姆斯特伦、理查德·J·西尔维斯特、大卫·E·克劳福德等。一项个体患者数据荟萃分析，比较膀胱内注射丝裂霉素C与卡介苗治疗非肌层浸润性膀胱癌的随机研究的长期结果。《欧洲泌尿外科杂志》2009年；56卷：247 - 256页。 - Suppr | 超能文献

Re: Per-Uno Malmström, Richard J. Sylvester, David E. Crawford, et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer. Eur Urol 2009;56:247-56.

作者信息

Lamm Donald, Böhle Andreas, Palou Joan, Persad Raj, Brausi Maurizio, Colombel Marc, Akaza Hideyuki, Buckley Roger

出版信息

Eur Urol. 2010 Feb;57(2):e7-9; author reply e10-1. doi: 10.1016/j.eururo.2009.10.033. Epub 2009 Nov 10.

DOI:10.1016/j.eururo.2009.10.033

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Re: Per-Uno Malmström, Richard J. Sylvester, David E. Crawford, et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer. Eur Urol 2009;56:247-56.回复：佩尔-乌诺·马尔姆斯特伦、理查德·J·西尔维斯特、大卫·E·克劳福德等。一项个体患者数据荟萃分析，比较膀胱内注射丝裂霉素C与卡介苗治疗非肌层浸润性膀胱癌的随机研究的长期结果。《欧洲泌尿外科杂志》2009年；56卷：247 - 256页。

Eur Urol. 2010 Feb;57(2):e7-9; author reply e10-1. doi: 10.1016/j.eururo.2009.10.033. Epub 2009 Nov 10.

2

Re: Per-Uno Malmström, Richard J. Sylvester, David E. Crawford, et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer. Eur Urol 2009;56:247-56.回复：佩尔-乌诺·马尔姆斯特伦、理查德·J·西尔维斯特、大卫·E·克劳福德等人。一项针对比较膀胱内注射丝裂霉素C与卡介苗治疗非肌层浸润性膀胱癌的随机研究长期结果的个体患者数据荟萃分析。《欧洲泌尿外科杂志》2009年；56：247 - 56。

Eur Urol. 2010 Aug;58(2):e23; author reply e24-5. doi: 10.1016/j.eururo.2010.05.032. Epub 2010 Jun 2.

3

Re: Willem Oosterlinck, Ziya Kirkali,Richard Sylvester, et al. Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTCGenito-urinary Group Randomized Phase 2 Trial (30993). Eur Urol 2011;59:438-46.回复：威廉·奥斯特林克、齐亚·基尔卡利、理查德·西尔维斯特等。膀胱原位癌患者序贯膀胱内丝裂霉素C与卡介苗化疗免疫疗法及单纯卡介苗化疗免疫疗法：欧洲癌症研究与治疗组织泌尿生殖组随机2期试验（30993）结果。《欧洲泌尿外科杂志》2011年；59卷：438 - 46页

Eur Urol. 2011 Jul;60(1):e1; author reply e2-3. doi: 10.1016/j.eururo.2011.03.050. Epub 2011 Apr 5.

4

An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer.一项针对非肌层浸润性膀胱癌患者，比较膀胱内注射丝裂霉素C与卡介苗的随机研究长期结果的个体患者数据荟萃分析。

Eur Urol. 2009 Aug;56(2):247-56. doi: 10.1016/j.eururo.2009.04.038. Epub 2009 Apr 24.

5

Re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al. Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder. Eur Urol 2010;57:766-73.回复：理查德·J·西尔维斯特、毛里齐奥·A·布劳西、维姆·J·柯克尔斯等。欧洲癌症研究与治疗组织泌尿生殖系统组30911号随机3期研究的长期疗效结果：比较表柔比星、卡介苗以及卡介苗加异烟肼膀胱灌注治疗中高危Ta T1期膀胱尿路上皮癌患者的疗效。《欧洲泌尿外科杂志》2010年；57卷：766 - 73页

Eur Urol. 2010 Jun;57(6):e57; author reply e58-9. doi: 10.1016/j.eururo.2010.02.037. Epub 2010 Mar 15.

6

Long-term efficacy of maintenance bacillus Calmette-Guérin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study with a 20-year follow-up.卡介苗维持疗法与丝裂霉素C维持膀胱灌注疗法对无原位癌的频繁复发TaT1肿瘤的长期疗效：一项随访20年的前瞻性随机FinnBladder I研究的亚组分析

Eur Urol. 2009 Aug;56(2):260-5. doi: 10.1016/j.eururo.2009.04.009. Epub 2009 Apr 16.

7

Is intravesical bacillus Calmette-Guérin better than mitomycin for intermediate-risk bladder cancer?对于中危膀胱癌，膀胱内灌注卡介苗比丝裂霉素更好吗？

Eur Urol. 2009 Aug;56(2):257-8; discussion 258-9. doi: 10.1016/j.eururo.2009.04.041. Epub 2009 May 3.

8

Results of a randomized phase III trial of sequential intravesical therapy with mitomycin C and bacillus Calmette-Guerin versus mitomycin C alone in patients with superficial bladder cancer.一项针对浅表性膀胱癌患者的随机III期试验结果：丝裂霉素C与卡介苗序贯膀胱内治疗对比单纯丝裂霉素C治疗。

J Urol. 1998 Nov;160(5):1668-71; discussion 1671-2.

9

Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression.卡介苗与丝裂霉素C治疗浅表性膀胱癌的对比研究：肿瘤进展对比研究的正式荟萃分析

Urology. 2004 Apr;63(4):682-6; discussion 686-7. doi: 10.1016/j.urology.2003.11.049.

10

Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials.卡介苗与化疗用于膀胱原位癌患者膀胱内治疗的比较：随机临床试验已发表结果的荟萃分析

J Urol. 2005 Jul;174(1):86-91; discussion 91-2. doi: 10.1097/01.ju.0000162059.64886.1c.